NeuCyte, Inc.

1230 Bordeaux Dr
United States

Show jobs for this employer

1 article with NeuCyte, Inc.

  • SUNNYVALE, Calif., May 8, 2018 /PRNewswire/ -- NeuCyte, Inc., a leading neuroscience drug discovery company, announced the closing of a Series A financing round of $6.7 million, for a totaled funding of more than $8 million. NeuCyte's initial investors, Cowin Venture and Leaguer Ventures, led the round.